IFNG and Alzheimer disease: While both BM-MSCs and AD-MSCs similarly inhibit NK cell proliferation, BM-MSCs demonstrate significantly stronger suppression of NK cell cytotoxicity and greater reduction of IFN-γ secretion compared to AD-MSCs [205].